{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T07:10:34Z","timestamp":1765609834963,"version":"build-2065373602"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pregnancy Hypertension"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.preghy.2018.02.011","type":"journal-article","created":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T02:56:15Z","timestamp":1519613775000},"page":"12-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["To study the changes in fetal hemodynamics with intravenous labetalol or nifedipine in acute severe hypertension"],"prefix":"10.1016","volume":"15","author":[{"given":"Shalini","family":"Gainder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.C.","family":"Saha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahesh","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.preghy.2018.02.011_b0005","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.bpobgyn.2015.04.001","article-title":"The hypertensive disorders of pregnancy (29.3)","volume":"29","author":"Magee","year":"2015","journal-title":"Best Practice Res. Clin. Obstetr. Gynaecol."},{"issue":"8","key":"10.1016\/j.preghy.2018.02.011_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11906-014-0454-8","article-title":"Pre-eclampsia: an update","volume":"16","author":"von Dadelszen","year":"2014","journal-title":"Curr. Hypertens Rep."},{"issue":"2","key":"10.1016\/j.preghy.2018.02.011_b0015","first-page":"105","article-title":"Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy, Pregnan","volume":"4","author":"Magee","year":"2014","journal-title":"Hyperten. Int. J. Women's Cardiovasc. Health"},{"key":"10.1016\/j.preghy.2018.02.011_b0020","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.bpobgyn.2016.05.005","article-title":"Preventing deaths due to the hypertensive disorders of pregnancy","volume":"36","author":"von Dadelszen","year":"2016","journal-title":"Best Practice Res. Clin. Obstetr. Gynaecol."},{"key":"10.1016\/j.preghy.2018.02.011_b0025","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1053\/j.semperi.2008.04.010","article-title":"Fetal growth restriction","volume":"32","author":"Miller","year":"2008","journal-title":"Semin. Perinatol."},{"key":"10.1016\/j.preghy.2018.02.011_b0030","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0301-2115(00)00383-3","article-title":"Management and monitoring of severe preeclampsia","volume":"96","author":"Bolte","year":"2001","journal-title":"Eur. J. Obstet Gynecol. Reprod. Biol."},{"key":"10.1016\/j.preghy.2018.02.011_b0035","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejogrb.2006.02.015","article-title":"Severe hypertension in pregnancy: Hydralazine or labetalol. A randomized clinical trial","volume":"128","author":"Vigil-De Gracia","year":"2006","journal-title":"Eur. J. Obstet Gynecol. Reprod. Biol."},{"key":"10.1016\/j.preghy.2018.02.011_b0040","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1067\/mob.2000.107928","article-title":"Working group report on high blood pressure in pregnancy","volume":"183","author":"Report of the National High Blood Pressure Education Program","year":"2000","journal-title":"Am. J. Obstet Gynecol."},{"key":"10.1016\/j.preghy.2018.02.011_b0045","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0029-7844(01)01747-1","article-title":"Diagnosis and management of preecampsia and eclampsia","volume":"99","author":"ACOG Committee on Practice Bulleteins-Obstetrics","year":"2002","journal-title":"Obstet Gynecol."},{"key":"10.1016\/j.preghy.2018.02.011_b0050","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3109\/10641959909016200","article-title":"Antepartum middle mean cerebral blood flow velocity correlation with maternal hemodynamics","volume":"18","author":"Williams","year":"1999","journal-title":"Hypertens Pregnancy"},{"issue":"5","key":"10.1016\/j.preghy.2018.02.011_b0055","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/AOG.0b013e3182a9ea68","article-title":"Oral nifedipine or intravenous labetalol for hypertensive emergency in pregnancy","volume":"122","author":"Shekhar","year":"2013","journal-title":"Obstet Gynecol."},{"key":"10.1016\/j.preghy.2018.02.011_b0060","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ultrasmedbio.2010.10.006","article-title":"Changes in Fetal and Maternal Doppler parameters in acute severe hypertension Treament with Hydralazine or Labetalol","volume":"37","author":"Baggio","year":"2011","journal-title":"Ultrasound Med. Biol."},{"key":"10.1016\/j.preghy.2018.02.011_b0065","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1471-0528.1991.tb10339.x","article-title":"Maternal and fetal haemodyanmics in hypertensive pregnancies during maternal treatment with intravenous hydralazine or labetalaol","volume":"98","author":"Harper","year":"1991","journal-title":"Br. J. Obstet Gynaecol."}],"container-title":["Pregnancy Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778917304993?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778917304993?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:52:08Z","timestamp":1761897128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210778917304993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":13,"alternative-id":["S2210778917304993"],"URL":"https:\/\/doi.org\/10.1016\/j.preghy.2018.02.011","relation":{},"ISSN":["2210-7789"],"issn-type":[{"type":"print","value":"2210-7789"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"To study the changes in fetal hemodynamics with intravenous labetalol or nifedipine in acute severe hypertension","name":"articletitle","label":"Article Title"},{"value":"Pregnancy Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preghy.2018.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V. on behalf of International Society for the Study of Hypertension in Pregnancy.","name":"copyright","label":"Copyright"}]}}